|
Table of Contents
1. Report Overview
1.1 Overview of 3D Printing for Healthcare: Industry and Market 2015-2025
1.2 3D Printing for Healthcare, Market Segmentation
1.3 Market Definition
1.4 How This Report Delivers
1.5 Main Questions Answered by This Analytical Report
1.6 Why You Should Read This Report
1.7 Methods of Research and Analysis
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. Introduction to 3D Printing for the Healthcare Industry
2.1 3D Printing
2.1.1 The Original 3D Printing Process
2.1.2 Selective Laser Sintering (SLS)
2.1.3 Direct Metal Laser Sintering (DMLS)
2.1.4 Electron Beam Melting (EBM)
2.1.5 Stereolithography (SLA)
2.2 Bio-printing: The Printing of Living Cells
2.2.1 How 3D Printing With Living Tissue Works
2.2.2 The Near- and Long-Term Applications for 3D Bio-printing
2.2.3 Current Problems With 3D Bio-printing
2.3 The 3D Printing of Pharmaceuticals
2.3.1 3D Printing Technology in Drug Discovery
2.4 Classifying Medical Devices
2.4.1 The US Medical Devices Classification System
2.4.2 The EU Medical Devices Classification System
3. The 3D Printing Market for the Healthcare Industry, 2015-2025
3.1 The 3D Printing Market for Healthcare in 2013: Technology vs. Products
3.2 3D Printed Products in the Healthcare Industry: A Breakdown by Application
3.3 The 3D Printing Market for Healthcare: A Global Revenue Forecast 2015-2025
3.4 Driving and Restraining Forces Affecting That Industry
3.5 The 3D Printing Market for Healthcare: Technology vs. Products Revenue Forecast 2015-2025
3.5.1 Technology: Revenue Forecast 2015-2025
3.5.2 Drivers and Restraints in the 3D Printing Technology Submarket
3.5.3 Products: Revenue Forecast 2015-2025
3.6 The 3D Printing Market for Healthcare: Application Submarket Revenue Forecasts 2015-2025
3.6.1 Dental Products: Revenue Forecast 2015-2025
3.6.2 Medical Implants: Revenue Forecast 2015-2025
3.6.2.1 Medical Implants: Patient-Specific Orthopaedic and Cranio-maxillofacial Implants Are Produced Using 3D Printing Technology
3.6.2.2 The Driving and Restraining Factors Surrounding 3D Printed Medical Implants, 2015
3.6.3 Bio-printed Tissue: Revenue Forecast 2015-2025
3.6.4 Bio-printed Tissue: Commercial Launch in Q4 2014
3.6.5 Other Applications: Revenue Forecast 2015-2025
3.6.6 Other Applications: Medical Modelling, Prototypes and Pharmaceuticals
4. Leading National Markets for 3D Printing in Healthcare, 2015-2025
4.1 Leading National Markets – 3D Printing for Healthcare, 2013
4.2 Leading National Markets: Comparison of Revenue and Market Share, 2019 and 2025
4.3 Leading National Markets: 3D Printing for Healthcare, Grouped Revenue Forecasts, 2015-2025
4.4 The US Will Remain the Largest National Market Throughout the Forecast Period
4.4.1 Pioneering Use of 3D Printed Medical Implants in the US
4.4.2 FDA Regulatory Requirements: Abridged Pathways Encourage Innovation
4.5 The EU5 Account for 30.55% of the Market in 2013, But How Will This Change During the Forecast Period?
4.5.1 Germany Will Remain the Largest Market of the EU5 Throughout the Forecast Period
4.5.2 France: Strong Growth but a Decreasing Market Share
4.5.3 The UK: A Strong Network for 3D Printed Medical Implants Will Stimulate Sales of those Products
4.5.4 Italian Orthopaedic Device Manufacturers are Prominent Consumers of Arcam’s AM Technology
4.5.5 Spain: the Smallest Consumer in the EU5
4.6 Japan: Growth Will be Driven by Domestic and International Innovation
4.7 China: Domestic Innovation is Keeping Pace With the Western World
4.8 Will 3D Printing Penetrate the Russian Healthcare Market?
4.9 Brazil: A Rapidly Growing Dental Market Presents Opportunities for 3D Printing
4.10 The Indian Market is at an Early Stage
4.11 The RoW Market is Fast Growing
5. Market Leading Organisations in 3D Printing for Healthcare
5.1 Industry leaders in 2014
5.2 Organisations in the Medical Implants Sector
5.2.1 Stratasys: Total Revenues Up Over 80% from 2013
5.2.2 3D Systems: 574% Growth in Healthcare Revenues since 2010
5.2.3 Tissue Regeneration Systems: Commercialising 3D Printed Bioresorbable Skeletal Reconstruction Implants
5.2.4 Oxford Performance Materials: Selling Two FDA Approved Facial Reconstruction Implants
5.2.5 EOS: A Manufacturer of 3D Printers
5.2.6 Within Technologies: A Manufacturer of Software for 3D Printing
5.2.6.1 Within Medical: A New Initiative Combining Medical Implant Design Software and a 3D Printing Manufacturing Program
5.2.7 C&A Tool: Manufacturing Parts for the Surgical, Orthopaedic, Implant and Tooling Fields
5.2.8 Tronrud Engineering: A Provider of DMLS Since November 2011
5.2.9 Alphaform AG: Focussing on its 3D Printing Business
5.2.10 3T RPD Ltd: A UK-Based AM Company
5.2.11 Arcam AB Achieving Rapid Growth Since 2012
5.2.12 Xilloc Medical: Patient-Specific Implants from Design to Production
5.2.13 Renishaw: UK-based 3D Printer Manufacturer
5.2.14 Fripp Design and Research: Developed Picsima Technology for Printing Soft Tissue Prostheses
5.2.15 Materialise: A Global Software and Printing Services Provider
5.2.16 4WEB Medical: Over 3000 Spinal Implants Currently In Use
5.2.17 Replica 3dm: Offering Medical Models for the NHS
5.3 Organisations in the 3D Bio-printing Sector
5.3.1 Organovo: Offering the First 3D Bio-printed Tissue for Sale
5.3.2 RegenHU: Creating 3D Bio-printers and BioInks
5.3.3 Bio 3D Technologies: The World’s First Modular Bio-printer
5.3.4 Osteopore International: Two FDA Approved Products
5.3.5 EnvisionTEC: 3D Printing and Bio-printing Solutions
5.3.6 Rainbow Biosciences: Bio-printing Based on Magnetic Nanoparticles
5.3.7 Wake Forest Institute for Regenerative Medicine: 3D Bio-printing Research
5.3.7.1 Timeline for Commercially Available Therapeutic Applications
5.3.7.2 Commercial Applications: Drug Development
5.4 Organisations in Other Industry Sectors
5.4.1 Aprecia Pharmaceuticals: Oral Drug Delivery System Produced by 3D Printing Technology
5.4.2 The Cronin Group, University of Glasgow: Working on the 3D Printing of Pharmaceuticals
6. 3D Printing for the Healthcare Industry: The R&D Pipeline, 2014
6.1 R&D in the Field of Medical Implants
6.1.1 Improving Biocompatibility of 3D Printed Medical Implants with Vitamin B2
6.1.2 3D Printed Intervertebral Discs Could Look Forward to a Share of a $90bn Market
6.1.3 3D Printing of Bionic Organs With Enhanced Functionality
6.1.4 Returning Vision: Printing a Bionic Eye
6.2 R&D in the Field of Bioengineering
6.2.1 3D Printing of Skin Grafts: In Hospitals Within 10 Years?
6.2.2 The Production of Implantable Cartilage Using 3D Printing
6.2.3 3D Printing Blood Vessels is a Step Towards the Fabrication of Organs
6.2.3.1 Work at the University of Pennsylvania and MIT
6.2.3.2 Work at Fraunhofer
6.2.3.3 Work at Harvard
6.2.3.4 Work at The University of Iowa
6.2.4 3D Printing of Replacement Ears for Reconstructive Surgery
6.2.5 3D Printing to Fabricate Artificial Heart Valves
6.2.6 3D Printing of Nipple Areola Complex Graft for Reconstructive Surgery
6.2.7 3D Printing of Human Embryonic Stem Cells
6.3 R&D in Other Fields
6.3.1 The 3D Printing of Pharmaceuticals: The Potential to Improve Access to Pharmaceuticals in Remote Corners of the World?
6.3.2 3D Printing Pills: University of Central Lancashire
6.3.3 Bio-robots for Targeted Drug Delivery
7. Qualitative Analysis of the 3D Printing Industry for Healthcare, 2015 Onwards
7.1 3D Printing Industry for Healthcare 2014: Strengths and Weaknesses
7.1.1 Annual Growth Rate at Highest Levels To Date
7.1.2 Demand for Customised Products is High
7.1.3 3D Printed Products Can Improve Health Outcomes and Reduce Costs
7.1.4 Time and Resources Can be Saved
7.1.5 3D Printing Can Produce Complex Shapes and Parts
7.1.6 3D Printing Technology is Advancing Rapidly
7.1.7 3D Printing is Expensive
7.1.8 Economies of Scale are not Achieved Using Current Technology
7.1.9 A More Sophisticated Technology Requires Fewer Workers and New Skills
7.1.10 Access to Technology and Expertise Currently Limited
7.2 Opportunities and Threats Facing the Industry, 2015-2025
7.2.1 Governments are Funding 3D Printing R&D Projects
7.2.2 Increasing Demand for Personalised Medicine Represents a Lucrative Opportunity
7.2.3 There is Considerable Media Interest in the Technology
7.2.4 New Applications for 3D Printing Technology are Being Developed
7.2.5 Opportunities Exist in Post-Production Finishing
7.2.6 Regulatory Guidelines Must be Clarified
7.2.7 Long-term Studies of 3D Printed Medical Products Do Not Exist
7.2.8 Legal Questions Have Yet to be Answered
7.2.9 High Volume Manufacturing is More Economical Using Traditional Methods
7.3 A STEP Analysis of the 3D Printing Industry for Healthcare, 2015-2025
7.3.1 Social Influences on Market Trends
7.3.2 Technological Influences on Market Trends
7.3.3 Economic Influences on the Market
7.3.4 Political Influences on the Market
8. Research Interviews
8.1 Interview with Michael Renard, Executive Vice President, Commercial Operations, Organovo
8.1.1 On the Applications for 3D Bio-printing
8.1.2 On the Commercial Prospects of the Technology
8.1.3 On Potential Factors That Could Inhibit Development
8.1.4 On Their Newly Released exVive3D Liver Human Tissue
8.1.5 On the Future of Organovo and the 3D Bio-printing Industry
8.2 Interview with Jim Fitzsimmons, President and CEO, Tissue Regeneration Systems
8.2.1 On the Background of TRS
8.2.2 On TRS’ Product Portfolio
8.2.3 On Their Commercialisation Strategy
8.2.4 On TRS’ Future
8.3 Interview with Matthew Sherry, Managing Director, Replica 3dm
8.3.1 On the History Behind Replica 3dm
8.3.2 On Their Services and R&D Pipeline
8.3.3 On Replica 3dm’s Growth Plans
8.3.4 On the 3D Printing For Healthcare Industry
8.4 Interview with Professor Lee Cronin, Regius Chair of Chemistry, University of Glasgow
8.4.1 On the Cronin Group’s 3D Printed Technology
8.4.2 On Commercialisation Opportunities for Their Technology
8.5 Interview with Peter Leys, Executive Chairman, Materialise N.V.
8.5.1 On the Beginning of Materialise N.V.
8.5.2 On the Medical Products and Services Offered by Materialise N.V.
8.5.3 On Materialise’s Most Lucrative Products and Markets in 2015 and Beyond
8.5.4 On Regulatory Challenges Facing 3D Printing in the Healthcare Industry
8.5.5 On the Prospects of Materialise N.V. Over the Forecast Period
8.6 Interview with Andy Middleton, General Manager, EMEA (Europe, Middle East and Africa), Stratasys
8.6.1 On Stratasys’ Offerings for the Healthcare Industry
8.6.2 On the Demand for 3D Printing in Healthcare
8.6.3 On the Future of 3D Printing in the Healthcare Industry
8.7 Interview with Dr Lothar Koch, Head of Biofabrication Group in the Nanotechnology Department, Laser Zentrum Hannover
8.7.1 On Laser-Assisted Bio-printing
8.7.2 On the Uses of 3D Printed Tissue
8.7.3 On 3D Printed Tissue vs. Traditional In Vitro Models
8.7.4 On 3D Printed Tissue for Transplantation
8.7.5 On Research in the Field
8.7.6 On the Timeline for Commercial Availability
9. Conclusions from Our Study
9.1 The 3D Printing Market for the Healthcare Industry: Technology vs. End Products, 2015-2025
9.2 3D Printed Products for the Healthcare Industry by Application: Comparison of Revenue, 2013, 2019 and 2025
9.3 The Leading National Markets for 3D Printing in the Healthcare Industry, 2015-2025
9.4 Trends in the Industry and Market
9.4.1 Governments Want To Be Leaders in the Field
9.4.2 Personalised Medical Products Are Penetrating The Market
9.4.3 3D Printing Technology is Already Established in the Field of Dentistry
9.4.4 Bio-printing Will Take-Off Over The Next 10 years
9.4.5 Submarkets Will Expand – Systems, Software, Raw Materials & Products
List of Tables
Table 1.1 3D Printed Products for Healthcare by Application: Revenue ($m) and Market Share (%) Forecasts, 2014-2025
Table 2.1 The US Classification of Medical Devices
Table 2.2 The EU Classification of Medical Devices
Table 3.1 Breakdown of the Market by Technology and Products: Revenue ($m) and Market Share (%), 2013
Table 3.2 3D Printed Products for Healthcare by Application: Revenue ($m) and Market Share (%), 2013
Table 3.3 3D Printing in the Healthcare Industry: Overall World Revenue ($m) Forecast, 2014-2025
Table 3.4 3D Printing Technology for Healthcare: Revenue Forecast ($m), 2014-2025
Table 3.5 3D Printed Products for Healthcare: Revenue Forecast ($m), 2014-2025
Table 3.6 3D Printed Products for Healthcare by Application: Revenue ($m) and Market Share (%) Forecasts, 2014-2025
Table 3.7 3D Printed Dental Products: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 3.8 3D Printed Medical Implants: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 3.9 Bio-printed Tissue: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 3.10 Other Applications: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.1 Leading National Markets for 3D Printing Technology and 3D Printed Products for Healthcare: Revenue ($m) and Market Share (%), 2013
Table 4.2 Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Comparisons of Revenue ($m) and Market Share (%), 2019 and 2025
Table 4.3 Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Revenue Forecasts ($m), 2014-2025
Table 4.4 The US 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.5 The EU5: National Revenue ($m) and Market Share (%) Forecasts, 2014-2025
Table 4.6 The German 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.7 The French 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.8 The UK 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.9 The Italian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.10 The Spanish 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.11 The Japanese 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.12 The Chinese 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.13 The Russian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.14 The Brazilian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.15 The Indian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.16 RoW Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 5.1 Prominent Organisations in the 3D Printing Market for the Healthcare Industry, End of 2014
Table 5.2 Prominent Organisations in the Medical Implant Market, End of 2014
Table 5.3 Stratasys’ Acquisition History, 2013-2014
Table 5.4 3D Systems Healthcare Revenue ($m) and Share (%) of Total Revenue, 2010-2014
Table 5.5 3D Systems Healthcare-Related Acquisition History, 2012-2014
Table 5.6 Medical Implants Designed by Within Technologies' Software, 2014
Table 5.7 Alphaform AG’s Revenue ($m), 2010-2014
Table 5.8 Arcam Revenues ($m), 2010-2014
Table 5.9 Arcam: Breakdown of System Sales to the Medical Implant Industry by Country, 1997-2013
Table 5.10 Materials Used by Xilloc Medical, 2014
Table 5.11 Prominent Organisations in the 3D Bio-printing Market, 2014
Table 5.12 EnvisionTEC 3D Printing Systems for the Medical and Dental Industries, 2014
Table 5.13 Prominent Organisations in Other Industry Sectors Using 3D Printing, 2014
Table 6.1 Improving Biocompatibility of 3D Printed Medical Implants: Main Facts, 2014
Table 6.2 3D Printing Intervertebral Discs: Main Facts, 2014
Table 6.3 3D Printing of Bionic Organs: Main Facts, 2014
Table 6.4 3D Printing of Bionic Eye: Main Facts, 2014
Table 6.5 3D Printing of Skin Grafts: Main Facts, 2014
Table 6.6 3D Printed Cartilage: Main Facts, 2014
Table 6.7 3D Printing of Blood Vessels: Main Facts, 2014
Table 6.8 3D Printing of Replacement Human Ears: Main Facts, 2014
Table 6.9 3D Printing of Heart Valves: Main Facts, 2014
Table 6.10 3D Printing of Pharmaceuticals: Main Facts, 2014
Table 7.1 Strengths and Weaknesses of the 3D Printing Industry for Healthcare, 2014-2015
Table 7.2 Opportunities and Threats Facing the Industry and Market, 2015-2025
Table 7.3 Governmental Funding for 3D Printing, 2011-2014
Table 7.4 STEP Analysis: Social, Technological, Economic and Political Forces Influencing the 3D Printing Market for Healthcare, 2015-2025
Table 7.5 Main Technological Advances in 3D Printing to End of 2014
List of Figures
Figure 1.1 Global 3D Printing for Healthcare Market Segmentation Overview
Figure 3.1 Breakdown of the Market by Technology and Products: Market Share (%), 2013
Figure 3.2 3D Printed Products for Healthcare by Application: Market Share (%), 2013
Figure 3.3 3D Printing in the Healthcare Industry: An Overarching Revenue Forecast ($m), 2015-2025
Figure 3.4 3D Printing in the Healthcare Industry: Annual Growth Rates, 2015-2025
Figure 3.5 Driving and Restraining Factors of 3D Printing for Healthcare, 2015
Figure 3.6 3D Printing Technology for Healthcare: Market Share (%), 2019
Figure 3.7 3D Printing Technology for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 3.8 Driving and Restraining Factors of 3D Printing Technology in the Healthcare Industry, 2015
Figure 3.9 3D Printed Products for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 3.10 3D Printed Products and Technology for Healthcare: Market Share (%), 2025
Figure 3.11 3D Printed Products for Healthcare by Application: Revenue Forecast ($m), 2014-2025
Figure 3.12 3D Printed Products by Application: Market Share (%), 2025
Figure 3.13 3D Printed Dental Products: Revenue Forecast ($m), 2014-2025
Figure 3.14 Driving and Restraining Factors of the 3D Printed Dental Product Market, 2015
Figure 3.15 3D Printed Medical Implants: Revenue Forecast ($m), 2014-2025
Figure 3.16 Driving and Restraining Factors of the 3D Printed Medical Implants Market, 2015
Figure 3.17 Bio-printed Tissue: Revenue Forecast ($m), 2014-2025
Figure 3.18 Driving and Restraining Factors of the 3D Bio-printing Market, 2015
Figure 3.19 Other Applications: Revenue Forecast ($m), 2014-2025
Figure 3.20 The Driving and Restraining Factors of the Market for Other Applications, 2015
Figure 4.1 Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Market Share (%), 2013
Figure 4.2 Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Market Share Forecast (%), 2013, 2019, 2025
Figure 4.3 Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Grouped Revenue Forecast ($m), 2014-2025
Figure 4.4 The US 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.5 The EU5 3D Printing Market for Healthcare: Market Share by Country (%), 2013
Figure 4.6 The EU5: National Revenue Forecasts ($m), 2014-2025
Figure 4.7 The German 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.8 The French 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.9 The UK 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.10 The Italian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.11 The Spanish 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.12 The Japanese 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.13 The Chinese 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.14 The Russian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.15 The Brazilian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.16 The Indian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.17 RoW 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 5.1 3D Systems Healthcare Revenue ($m), 2010-2014
Figure 5.2 Alphaform AG’s Revenue ($m), 2010-2014
Figure 5.3 Arcam: Breakdown of System Sales by Industry, 2005-2014
Figure 5.4 Arcam: Breakdown of System Sales by Location, 2005-2014
Figure 5.5 Arcam Revenues ($m), 2010-2014
Figure 5.6 Arcam: Breakdown of System Sales to the Medical Implant Industry by Country, 1997-2013
Figure 5.7 Materialise: Revenue Breakdown by Application, 2014 (Q1-Q3)
Figure 6.1 3D Printing Technology for Healthcare: Outline of the R&D Pipeline, 2014
Figure 8.1 Orthodontic Model Produced on a Stratasys Objet30 OrthoDesk 3D Printer
Figure 8.2 VeinViewer® Flex Designed Using Stratasys 3D Printed Prototypes
Figure 8.3 VeinViewer® Displaying Blood Beneath the Surface of an Adult Female Hand
Figure 8.4 Jorge Vicente Lopes da Silva, Chief of Tridimensional Technologies Division (DT3D - CTI), Shows 12-year-old Boy’s Skull Model Produced on an Objet350 Connex Multi-material 3D Printer. That child Suffered an Accident and Lost Part of his Cranium.
Figure 9.1 3D Printing for the Healthcare Industry: Revenue Forecast ($m) Broken Down Into Technology and Products, 2014-2025
Figure 9.2 3D Printed Products for the Healthcare Industry by Application: Comparisons of Revenue ($m), 2013, 2019 and 2025
Figure 9.3 Leading National Markets in the 3D Printing Industry for Healthcare: Comparisons of Revenue ($m), 2013, 2019 and 2025
|
현재위치 : 
